BRISBANE, Australia, April 01, 2022 (GLOBE NEWSWIRE) -- Allkem Limited (ASX|TSX: “AKE”, the “Company”) provides an update on expected June quarter pricing for lithium carbonate and spodumene products.
Lithium carbonate
Strong market conditions continue to positively impact the price received for lithium carbonate from the Olaroz Lithium Facility. The June quarter FY22 average price received for lithium carbonate is expected to be approximately US$35,000/t FOB1 on sales of approximately 3,500 tonnes.
The preliminary March quarter FY22 sales price was approximately US$27,236/t FOB, 9% higher than the previous guidance.
Spodumene
Similarly strong conditions in the spodumene market are supporting advanced discussions for spodumene concentrate pricing in the June quarter of approximately US$5,000/t SC6% CIF on sales of approximately 50,000 tonnes.
March quarter sales of spodumene concentrate were completed at a price of approximately US$2,218/t SC6% CIF DMT which includes tonnes that were delayed from the December quarter.
March quarter report
The March quarter sales prices for lithium carbonate and spodumene concentrate are preliminary and indicative. The final prices will be provided in the March Quarterly Report which will be released on 14 April, 2022.
This release was authorised by Mr Martin Perez de Solay, CEO and Managing Director of Allkem Limited.
| Allkem Limited | Investor Relations & Media Enquiries | Connect | ||
1 “FOB” (Free On Board) excludes insurance and freight charges included in “CIF” (Cost, Insurance, Freight) pricing. Therefore, the Company’s reported prices are net of freight (shipping), insurance and sales commission. FOB prices are reported by the Company to provide clarity on the sales revenue that is recognised by SDJ, the joint venture company in Argentina
IMPORTANT NOTICES
This investor ASX/TSX release (Release) contains general information about the Company as at the date of this Release. The information in this Release should not be considered to be comprehensive or to comprise all of the material which a shareholder or potential investor in the Company may require in order to determine whether to deal in Shares of Allkem. The information in this Release is of a general nature only and does not purport to be complete. It should be read in conjunction with the Company’s periodic and continuous disclosure announcements which are available at allkem.co and with the Australian Securities Exchange (ASX) announcements, which are available at www.asx.com.au.